Document:

Exhibit
10.6

 

FutureTech
II Acquisition Corp.

128
Gail Drive

New
Rochelle, NY 10805

 

[__],
2022

 

Ladies
and Gentlemen:

 

FutureTech
II Acquisition Corp. (the “Company”), a blank check company formed for the purpose of acquiring one or more businesses or
entities (a “Business Combination”), intends to register its securities under the Securities Act of 1933, as amended (the
“Securities Act”), in connection with its initial public offering (“IPO”), pursuant to a registration statement
on Form S-1 (the “Registration Statement”).

 

The
undersigned hereby commits that it will purchase 467,575 units of the Company (the “Private Units”), each Private
Unit consisting of one share of Class A common stock of the Company, par value $0.0001 per share (the “Class A Common Stock”),
and one   warrant (the “Warrants”) with each whole warrant entitling its holder to purchase one (1) share of Class
A Common Stock, for a purchase price of $4,675,750 (the “Private Unit Purchase Price”).

 

The
undersigned hereby agrees that it will purchase an additional amount of units of the Company (the “Over-Allotment Units”),
up to a maximum of 52,500 Over-Allotment Units, or a maximum purchase price of $520,000 (the “Over-Allotment Unit Purchase
Price”, together with the Private Unit Purchase Price, the “Purchase Price”), in the event EF Hutton, division of Benchmark
Investments, LLC (“EF Hutton”) exercises its over-allotment option, such that the amount held in the trust account (as described
in the Registration Statement) does not fall below $10.20 per share for each share of Class A Common Stock sold in the IPO.

 

At
least twenty-four (24) hours prior to the effective date of the Registration Statement, the undersigned will cause the Private Unit Purchase
Price to be delivered to Nelson Mullins Riley & Scarborough LLP (“Nelson Mullins”), counsel for the Company, by wire
transfer as set forth in the instructions attached as Exhibit A to hold in a non-interest bearing account until the Company consummates
the IPO.

 

The
consummation of the purchase and issuance of the Private Units shall occur simultaneously with the consummation of the IPO and the consummation
of the purchase and issuance of the Over-Allotment Units shall occur simultaneously with the closing of any exercise of the over-allotment
option related to the IPO. Simultaneously with the consummation of the IPO, Nelson Mullins shall deposit the Private Unit Purchase Price,
without interest or deduction, into the trust fund (“Trust Fund”) established by the Company for the benefit of the Company’s
public shareholders as described in the Registration Statement. If the Company does not complete the IPO within ten (10) days from the
date of this letter, the Private Unit Purchase Price (without interest or deduction) will be returned to the undersigned.

 

Each
of the Company, and the undersigned acknowledges and agrees that Nelson Mullins is serving hereunder solely as a convenience to the parties
to facilitate the purchase of the Private Units and Nelson Mullins’s sole obligation under this letter agreement is to act with
respect to holding and disbursing the Private Unit Purchase Price as described above. Nelson Mullins shall not be liable to the Company,
EF Hutton or the undersigned or any other person or entity in respect of any act or failure to act hereunder or otherwise in connection
with performing its services hereunder unless Nelson Mullins has acted in a manner constituting gross negligence or willful misconduct.
The Company and the undersigned shall indemnify Nelson Mullins against any claim made against it (including reasonable attorney’s
fees) by reason of it acting or failing to act in connection with this letter agreement except as a result of its gross negligence or
willful misconduct. Nelson Mullins may rely and shall be protected in acting or refraining from acting upon any written notice, instruction
or request furnished to it hereunder and believed by it to be genuine and to have been signed or presented by the proper party or parties.

 

    	 

    	 

    

 

The
Private Units and Over-Allotment Units will be identical to the units to be sold by the Company in the IPO. Additionally, the undersigned
agrees:

 

	 	●	to
    vote the shares of Class A Common Stock included in the Private Units and Over-Allotment Units in favor of any proposed Business
    Combination;
	 	 	 
	 	●	not
    to propose, or vote in favor of, an amendment to the Company’s Amended and Restated Certificate of Incorporation that would
    affect the substance or timing of the Company’s obligation to redeem 100% of the Company’s shares of Class A Common Stock
    sold in the IPO if the Company does not complete an initial Business Combination within 12 months from the closing of the IPO (or
    up to 18 months from the closing of the IPO if the Company extends the period of time to consummate an initial Business Combination
    as described in more detail in the prospectus included in the Registration Statement), unless the Company provides the holders of
    shares of Class A Common Stock sold in the IPO with the opportunity to redeem their shares of Class A Common Stock upon approval
    of any such amendment at a per-share price, payable in cash, equal to the aggregate amount of the Trust Fund, including interest
    earned on Trust Fund and not previously released to the Company to pay the Company’s franchise and income taxes, divided by
    the number of then outstanding shares of Class A Common Stock sold in the IPO;
	 	 	 
	 	●	not
    to convert any shares of Class A Common Stock included in the Private Units and Over-Allotment Units into the right to receive cash
    from the Trust Fund in connection with a shareholder vote to approve either a Business Combination or an amendment to the provisions
    of the Company’s Amended and Restated Certificate of Incorporation, and not to tender the Private Units and Over-Allotment
    Units in connection with a tender offer conducted prior to the closing of a Business Combination;
	 	 	 
	 	●	the
    undersigned will not participate in any liquidation distribution with respect to the Private Units and Over-Allotment Units (but
    will participate in liquidation distributions with respect to any units or shares of Class A Common Stock purchased by the undersigned
    in the IPO or in the open market) if the Company fails to consummate a Business Combination;
	 	 	 
	 	●	that
    the Private Units, Over-Allotment Units and underlying securities will not be transferable until after the consummation of a Business
    Combination except (i) to the Company’s pre-IPO shareholders, or to the Company’s officers, directors, advisors and employees,
    (ii) transfers to the undersigned’s affiliates or its members upon its liquidation, (iii) to relatives and trusts for estate
    planning purposes, (iv) by virtue of the laws of descent and distribution upon death, (v) pursuant to a qualified domestic relations
    order, (vi) by private sales made in connection with the consummation of a Business Combination at prices no greater than the price
    at which the Private Units were originally purchased or (vii) to the Company for cancellation in connection with the consummation
    of a Business Combination, in each case (except for clause vii) where the transferee agrees to the terms of the transfer restrictions;
    and
	 	 	 
	 	●	the
    Private Units and Over-Allotment Units will include any additional terms or restrictions as is customary in other similarly structured
    blank check company offerings or as may be reasonably required by the underwriters in the IPO in order to consummate the IPO, each
    of which will be set forth in the Registration Statement.

 

    	 

    	 

    

 

The
undersigned acknowledges and agrees that the purchaser of the Private Units and Over-Allotment Units will execute agreements in form
and substance typical for transactions of this nature necessary to effectuate the foregoing agreements and obligations prior to the consummation
of the IPO as are reasonably acceptable to the undersigned, including but not limited to an insider letter.

 

The
undersigned hereby represents and warrants that:

 

	 	(a)	it
    has been advised that the Private Units and Over-Allotment Units have not been registered under the Securities Act;
	 	 	 
	 	(b)	it
    will be acquiring the Private Units and Over-Allotment Units for its account for investment purposes only;
	 	 	 
	 	(c)	it
    has no present intention of selling or otherwise disposing of the Private Units and Over-Allotment Units in violation of the securities
    laws of the United States;
	 	 	 
	 	(d)	it
    is an “accredited investor” as defined by Rule 501 of Regulation D promulgated under the Securities Act of 1933, as amended;
	 	 	 
	 	(e)	it
    has had both the opportunity to ask questions and receive answers from the officers and directors of the Company and all persons
    acting on its behalf concerning the terms and conditions of the offer made hereunder;
	 	 	 
	 	(f)	it
    is familiar with the proposed business, management, financial condition and affairs of the Company;
	 	 	 
	 	(g)	it
    has full power, authority and legal capacity to execute and deliver this letter and any documents contemplated herein or needed to
    consummate the transactions contemplated in this letter; and
	 	 	 
	 	(h)	this
    letter constitutes its legal, valid and binding obligation, and is enforceable against it.

 

This
letter agreement constitutes the entire agreement between the undersigned and the Company with respect to the purchase of the Private
Units and Over-Allotment Units, and supersedes all prior and contemporaneous understandings, agreements, representations and warranties,
both written and oral, with respect to the same.

 

    	 

    	 

    

 

	 	Very
    truly yours,
	 	 	 
	 	FutureTech
    Partners II LLC
	 	 	 
	 	By:	 
	 	Name:	Yuquan
Wang
	 	Title:	Manager

 

	Accepted
    and Agreed:   	 
	 	 	 
	FUTURETECH
    II ACQUISITION CORP.   	 
	 	 	 
	By:
    	 	 
	Name:	Yuquan
Wang	 
	Title:	Chief
Executive Officer	 

 

[Signature
page to Placement Unit Purchase Agreement]

 

    	 

    	 

    

 

Exhibit
A

 

Wire
Instructions

 

Bank
Name: [__]

Bank
Address: [__]

Account
Name: [__]

Account
Number: [__]

Routing/ABA
Number (Domestic Wires): [__]

Swift
Code (Foreign Wire): [__]

Note:
[__]EX-4.1

 Exhibit 4.1 

Execution Version 

R. R. DONNELLEY & SONS COMPANY 

and 
 WELLS FARGO BANK,
NATIONAL ASSOCIATION, as Trustee 
  
  

THIRTEENTH SUPPLEMENTAL INDENTURE 

Dated as of February 9, 2022 

to 
 Indenture dated as
of January 3, 2007 
  
  

6 1/2% Notes due 2023 

 TABLE OF CONTENTS 

 

							
	Article I	  

	
	DEFINITIONS	  

			
	 Section 1.1
	 	 Generally
	  	 	4	 
	
	Article II	  

	
	AMENDMENTS	  

			
	 Section 2.1
	 	 Certain Amendments to the Indenture
	  	 	4	 
	 Section 2.2
	 	 Certain Waivers to the Indenture
	  	 	7	 
	 Section 2.3
	 	 Effectiveness
	  	 	7	 
	
	Article III	  

	
	MISCELLANEOUS PROVISIONS	  

			
	 Section 3.1
	 	 Ratification of Indenture
	  	 	8	 
	 Section 3.2
	 	 Trustee Not Responsible for Recitals
	  	 	8	 
	 Section 3.3
	 	 Table of Contents, Headings, etc.
	  	 	8	 
	 Section 3.4
	 	 Counterpart Originals
	  	 	8	 
	 Section 3.5
	 	 Governing Law; Jury Trial Waiver
	  	 	9	 

  
 2 

 THIS THIRTEENTH SUPPLEMENTAL INDENTURE, dated as of February 9, 2022 (the
“Thirteenth Supplemental Indenture”), between R. R. Donnelley & Sons Company, a Delaware corporation, as issuer (the “Company”), and Wells Fargo Bank, National Association, a national banking association,
as trustee (the “Trustee”). 
 RECITALS: 

WHEREAS, the Company has executed and delivered to the Trustee an Indenture, dated as of January 3, 2007 (the “Base
Indenture” and, collectively with the Ninth Supplemental Indenture and the Eleventh Supplemental Indenture (each defined below), the “Indenture”), providing for the issuance by the Company from time to time of its unsecured
senior debentures, notes or other evidences of indebtedness to be issued in one or more series unlimited as to principal amount (the “Securities”); 

WHEREAS, the Company has executed and delivered to the Trustee a Ninth Supplemental Indenture, dated as of November 12, 2013 (the
“Ninth Supplemental Indenture”), and an Eleventh Supplemental Indenture, dated as of June 18, 2020, to the Base Indenture governing the 6 1/2% Notes due 2023 (the “Notes”); 

WHEREAS, pursuant to the terms of a consent solicitation statement, dated January 20, 2022 (the “Consent Solicitation
Statement”), the Company solicited consents to certain waivers and amendments to the Indenture with respect to the Notes and other Securities as set forth herein; 

WHEREAS, Section 8.02 of the Base Indenture provides that the Company and the Trustee may amend certain provisions of the Indenture or
the Notes with the consent of the registered holders (the “Holders”) of a majority in aggregate principal amount of the Notes then outstanding (excluding any Notes owned by the Company or any of its Affiliates), and such consent has
been received by the Company; 
 WHEREAS, the Company desires the Trustee to join with it in the execution and delivery of this Thirteenth
Supplemental Indenture, and in accordance with Sections 8.02, 8.06 and 10.04 of the Base Indenture, the Company has (i) duly adopted and delivered to the Trustee, resolutions of its Board of Directors authorizing the execution and delivery of
this Thirteenth Supplemental Indenture, (ii) delivered to the Trustee evidence reasonably satisfactory to the Trustee that Holders of a majority in aggregate principal amount of the Notes outstanding have given and, as of the date hereof, have
not withdrawn their consents to the amendments set forth in this Thirteenth Supplemental Indenture, and (iii) delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel stating that the execution of this Thirteenth
Supplemental Indenture is permitted by the Indenture and that all conditions precedent to its execution have been complied with, and the Indenture and this Thirteenth Supplemental Indenture are valid and binding obligations of the Company and are
enforceable in accordance with their terms; 
 WHEREAS, all things necessary to make this Thirteenth Supplemental Indenture a valid
agreement of the Company and the Trustee, in accordance with its terms, and a valid amendment of, and supplement to, the Indenture have been done; 

  
 3 

 NOW, THEREFORE, in consideration of the foregoing and for other good and valuable
consideration, the receipt and sufficiency of which is hereby acknowledged, the Company covenants and agrees with the Trustee, for the equal and ratable benefit of the Holders, that the Indenture is supplemented and amended, to the extent expressed
herein, as follows: 
 ARTICLE I 

DEFINITIONS 

Section 1.1    Generally. 

(a)    Capitalized terms used herein and not otherwise defined herein shall have the respective meanings ascribed thereto
in the Base Indenture. 
 (b)    The rules of interpretation set forth in the Base Indenture shall be applied hereto as
if set forth in full herein. 
 ARTICLE II 

AMENDMENTS 

Section 2.1    Certain Amendments to the Indenture. Solely with respect to the Notes, the Indenture is
hereby amended as follows: 
 (a)    the definition of “Change of Control” as set forth in Section 1.2 of
the Ninth Supplemental Indenture is hereby deleted in its entirety and replaced with the following: 
 “Change of
Control” means the occurrence of any of the following: (1) the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or
substantially all of the properties or assets of the Company and its Subsidiaries taken as a whole to any “person” (as that term is used in Section 13(d)(3) of the Exchange Act) other than the Company or one of its Subsidiaries or to
a Permitted Holder; or (2) the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any “person” (as that term is used in Section 13(d)(3) of the Exchange Act),
other than a Permitted Holder, becomes the beneficial owner, directly or indirectly, of more than 50% of the then outstanding number of shares of the Company’s voting stock. 

(b)    the following definitions are hereby inserted alphabetically into Section 1.2 of the Ninth Supplemental
Indenture: 
 “CAM” means Chatham Asset Management, LLC, a Delaware limited liability company, together with
certain of its Affiliates. 
 “Permitted Holder” means CAM and its respective Subsidiaries and Affiliates
and any person or group whose acquisition of beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act, or any successor 

  
 4 

 
provision) constitutes a Change of Control in respect of which a Change of Control Offer is made in accordance with the requirements of Section 4.1 hereof (or would result in a Change of
Control Offer in the absence of the waiver of such requirement by Holders in accordance with Section 4.1 hereof) shall thereafter constitute a Permitted Holder. 

(c)    Section 4.08 of the Base Indenture is hereby deleted in its entirety and replaced with the following: 

“So long as any Securities are outstanding, the Company will deliver to the Trustee a copy of all of the information and
reports referred to below: 
 (a) for so long as the Company is subject to the reporting requirements of Section 13 or
15(d) of the Exchange Act: 
 (1) within the time periods specified in the Commission’s rules and regulations, all quarterly and annual
reports on Forms 10-Q and 10-K, including a “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and, with respect
to annual information only, a report thereon by the Company’s certified independent accountants; and 
 (2) all current reports on Form
8-K; 
 (b) for so long as the Company is not subject to the reporting requirements
of Section 13 or 15(d) of the Exchange Act: 
 (1) within 120 days after the end of each fiscal year (or 150 days in the case of the
fiscal year of the Company ended on or around December 31, 2022), annual audited financial statements for such fiscal year, including a “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, with
respect to the periods presented prepared in accordance with GAAP and a report thereon by the Company’s certified independent accountants; 

(2) within 60 days after the end of each of the first three fiscal quarters of each fiscal year, unaudited financial statements (including
footnotes) for the interim period as of, and for the period ending on, the end of such quarter, including a “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for the Company with respect to the
periods presented prepared in accordance with GAAP; and 
 (3) promptly after the occurrence of any of the following
events, (and, in any case, not required to be sooner than five Business Days after the occurrence of any such event), current reports of the Company containing substantially all of the information that would be required to be filed
in a current report on Form 8-K under the 

  
 5 

 
Exchange Act on April 28, 2021 pursuant to Sections 1 and 4, Items 2.01, 2.03, 2.04(a), 5.01, 5.02(a)(1) (with respect to independent directors only), 5.02(b) (with respect to officers
and independent directors only), 5.02(c)(1) and (3), 5.02(d)(1), (2), (3) and (4) (in each case, with respect to independent directors only) 5.03(b) of Form 8-K (but excluding, for the avoidance of doubt,
financial statements and exhibits that would be required pursuant to Item 9.01 of Form 8-K, other than financial statements and pro forma financial information (in each case relating to transactions required
to be reported pursuant to Item 2.01 of Form 8-K) to the extent available (as determined in good faith by the Company)) if the Company had been a reporting company under the Exchange Act. 

To the extent any such information is not so filed or furnished, as applicable, within the time periods specified in this
Section 4.08 and such information is subsequently filed or furnished, as applicable, the Company shall be deemed to have satisfied its obligations with respect thereto at such time and any Default with respect thereto shall be deemed to have
been cured; provided that such cure shall not otherwise affect the rights of the Holders under Article SIX hereof if Holders of at least 25% in principal amount of the then total outstanding Securities have declared the principal of, premium,
if any, interest and any other monetary obligations on all the then outstanding Securities to be due and payable immediately and such declaration shall not have been rescinded or cancelled prior to such cure. 

(c) In addition to providing such information to the Trustee, the Company shall make available to Holders the information
required to be provided pursuant to clauses (1), (2) and (3) of the preceding paragraph, by posting such information to its website or on IntraLinks or any comparable password protected online data system or website. 

(d) Notwithstanding the foregoing, (a) the Company will not be required to deliver any information, certificates or
reports that would otherwise be required by (i) Section 302, Section 404 and Section 906 of the Sarbanes-Oxley Act of 2002, or related Items 307 or 308 of Regulation S-K, (ii) Item
10(e) of Regulation S-K promulgated by the Commission with respect to any non-generally accepted accounting principles financial measures contained therein or
(iii) Items 201, 402, 403, 405, 406, 407, 701 or 703 of Regulation S-K, (b) such reports will not be required to contain financial information required by Rule
3-09, Rule 3-10, Rule 13-01 or Rule 13-02 of Regulation
S-X or include any exhibits or certifications required by Form 10-K or Form 10-Q (or any successor forms) or related rules under
Regulation S-K and (c) such reports shall be subject to exceptions, exclusions and other differences consistent with the presentation of financial and other information in this offering memorandum and
shall not be required to present compensation or beneficial ownership information. 

  
 6 

 (e) The Company has agreed that, for so long as any Securities remain
outstanding during any period when the Company is not subject to Section 13 or 15(d) of the Exchange Act, or otherwise permitted to furnish the Commission with certain information pursuant to Rule
12g3-2(b) of the Exchange Act, it will furnish to the Holders and to prospective investors, upon their request, the information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act.

 (f) Notwithstanding this Section 4.08, the Company will be deemed to have delivered such reports and information
referred to above to the Holders and the Trustee for all purposes of this Indenture if the Company has filed such reports with the Commission via the EDGAR filing system (or any successor system) and such reports are publicly available. In addition,
the requirements of this Section 4.08 will be deemed satisfied and the Company will be deemed to have delivered such reports and information referred to above to the Holders for all purposes of this Indenture by the posting of reports and
information that would be required to be provided on the Company’s website. Delivery of such reports, information and documents to the Trustee is for informational purposes only and the Trustee’s receipt of such shall not constitute
constructive notice of any information contained therein or determinable from information contained therein, including the Company’s compliance with any of its covenants thereunder (as to which the Trustee is entitled to rely exclusively on an
Officers’ Certificate). The Trustee shall not be obligated to monitor or confirm, on a continuing basis or otherwise, the Company’s compliance with the covenants under this Indenture or with respect to any reports or other documents filed
with the Commission or posted on the Company’s website pursuant to this Indenture, or participate in any conference calls.” 

(d)    all references to Sections of the Indenture amended by this Thirteenth Supplemental Indenture shall mean such
Section as amended by this Thirteenth Supplemental Indenture. 
 Section 2.2    Certain Waivers to the
Indenture. Solely with respect to the Notes, the merger of Chatham Delta Acquisition Sub, Inc., a Delaware corporation, with and into the Company (the “Merger”) pursuant to the agreement and plan of merger, dated as of
December 14, 2021, as amended, restated, amended and restated, supplemented, waived or otherwise modified from time to time (the “Merger Agreement”), will not constitute a Change of Control under Section 1.2 of the Ninth
Supplemental Indenture. For the avoidance of doubt, the Company shall have no obligation to make a Change of Control Offer pursuant to Section 4.1 of the Ninth Supplemental Indenture in connection with the Merger. 

Section 2.3    Effectiveness. This Thirteenth Supplemental Indenture shall become effective upon the execution
and delivery hereof by the parties hereto. Notwithstanding the foregoing, the amendments and waivers set forth above in this Article II shall not become operative until immediately prior to the consummation of the Merger pursuant to the Merger
Agreement and will cease to be operative if the Merger is not consummated or the Consent Consideration (as defined in the Consent Solicitation Statement) with respect to the Notes is not paid in accordance with the terms of the Consent Solicitation
Statement. 

  
 7 

 ARTICLE III 

MISCELLANEOUS PROVISIONS 

Section 3.1    Ratification of Indenture. The Indenture, as supplemented by this Thirteenth
Supplemental Indenture, is in all respects ratified and confirmed, and this Thirteenth Supplemental Indenture shall be deemed part of the Indenture in the manner and to the extent herein and therein provided. 

Section 3.2    Trustee Not Responsible for Recitals. The recitals contained herein and in the Notes
shall be taken as the statements of the Company, and the Trustee assumes no responsibility for the correctness of the same. The Trustee makes no representations as to and shall not be responsible for the validity or sufficiency of this Thirteenth
Supplemental Indenture or of the Notes. The Trustee makes no representations as to and shall not be responsible for the Company’s 6.00% notes due 2024, 6.125% senior secured notes due 2026, 8.250% notes due 2027, 8.500% notes due 2029, 6.625%
debentures due 2029 and 8.820% debentures due 2031, the solicitation of consents and the consents of the Holders of the Notes. In entering into this Thirteenth Supplemental Indenture, the Trustee shall be entitled to the benefit of every provision
of the Indenture relating to the conduct or affecting the liability of or affording protection to the Trustee, whether or not elsewhere herein so provided. The Company hereby confirms to the Trustee that this Thirteenth Supplemental Indenture has
not resulted in a material modification of the Notes for Foreign Account Tax Compliance Act (“FATCA”) purposes. The Trustee shall assume that no material modification for FATCA purposes has occurred regarding the Notes, unless the
Trustee receives written notice of such modification from the Company. 
 Section 3.3    Table of Contents,
Headings, etc. The table of contents and headings of the Articles and Sections of this Thirteenth Supplemental Indenture have been inserted for convenience of reference only, are not to be considered a part hereof and shall in no way
modify or restrict any of the terms or provisions hereof. 
 Section 3.4    Counterpart Originals.
The parties may sign any number of copies of this Thirteenth Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. The exchange of copies of this Thirteenth Supplemental Indenture
and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this Thirteenth Supplemental Indenture as to the parties hereto and may be used in lieu of the original Thirteenth Supplemental Indenture
for all purposes. Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes. This Thirteenth Supplemental Indenture and any certificate, agreement or other document to be signed
in connection with this Thirteenth Supplemental Indenture and the transactions contemplated hereby shall be valid, binding, and enforceable against a party when executed and delivered by an authorized individual on behalf of the party by means of
(i) an original manual signature; (ii) a faxed, scanned, or photocopied manual signature or (iii) any other electronic signature permitted by the federal Electronic Signatures in Global and National Commerce Act, state enactments of
the Uniform Electronic Transactions 

  
 8 

 
Act and/or any other relevant electronic signatures law, including any relevant provisions of the Uniform Commercial Code (collectively, “Signature Law”), in each case to the
extent applicable. Each faxed, scanned or photocopied manual signature, or other electronic signature, shall for all purposes have the same validity, legal effect, and admissibility in evidence as an original manual signature. Each party hereto
shall be entitled to conclusively rely upon, and shall have no liability with respect to, any faxed, scanned or photocopied manual signature, or other electronic signature, of any other party and shall have no duty to investigate, confirm or
otherwise verify the validity or authenticity thereof. This Thirteenth Supplemental Indenture may be executed in any number of counterparts, each of which shall be deemed to be an original, but such counterparts shall, together, constitute one and
the same instrument. For the avoidance of doubt, original manual signatures shall be used for execution or indorsement of writings when required under the Uniform Commercial Code or other Signature Law due to the character or intended character of
the writings. 
 Section 3.5    Governing Law; Jury Trial Waiver. THIS THIRTEENTH SUPPLEMENTAL INDENTURE AND
THE NOTES SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. EACH OF THE COMPANY AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO A TRIAL BY JURY
IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS THIRTEENTH SUPPLEMENTAL INDENTURE OR THE TRANSACTIONS CONTEMPLATED HEREBY. 

[Signature Pages Follow] 

  
 9 

 IN WITNESS WHEREOF, the parties have caused this Thirteenth Supplemental Indenture to be
duly executed all as of the date and year first written above. 
  

					
	R. R. DONNELLEY & SONS COMPANY
		
	By:	 	 /s/ Terry D. Peterson

		 	Name:	 	Terry D. Peterson
		 	Title:	 	Executive Vice President and Chief Financial Officer

  
 [Thirteenth
Supplemental Indenture] 

 
					
	WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee
	
	By: Computershare Trust Company, N.A. as agent and attorney-in-fact
		
	By:	 	 /s/ Belinda Coleman

		 	Name:	 	Belinda Coleman
		 	Title:	 	Assistant Vice President

  
 [Thirteenth
Supplemental Indenture]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}]]